Hims & Hers Health Inc (NYSE: HIMS) kicked off on Monday, up 8.64% from the previous trading day, before settling in for the closing price of $19.32. Over the past 52 weeks, HIMS has traded in a range of $7.40-$30.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Consumer Defensive sector company grew by 60.52% over the past five years. While this was happening, its average annual earnings per share was recorded 859.44%. With a float of $177.25 million, this company’s outstanding shares have now reached $205.10 million.
Let’s look at the performance matrix of the company that is accounted for 1046 employees. In terms of profitability, gross margin is 77.58%, operating margin of 2.84%, and the pretax margin is 4.16%.
Hims & Hers Health Inc (HIMS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Household & Personal Products Industry. The insider ownership of Hims & Hers Health Inc is 18.87%, while institutional ownership is 56.08%. The most recent insider transaction that took place on Nov 18 ’24, was worth 1,233,162. Before that another transaction happened on Nov 18 ’24, when Company’s Officer proposed sale 472 for $19.42, making the entire transaction worth $9,166.
Hims & Hers Health Inc (HIMS) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported 0.05 earnings per share (EPS), lower than consensus estimate (set at 0.06) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 859.44% per share during the next fiscal year.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Take a look at Hims & Hers Health Inc’s (HIMS) current performance indicators. Last quarter, stock had a quick ratio of 1.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.42. Likewise, its price to free cash flow for the trailing twelve months is 28.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.43, a number that is poised to hit 0.18 in the next quarter and is forecasted to reach 0.91 in one year’s time.
Technical Analysis of Hims & Hers Health Inc (HIMS)
Hims & Hers Health Inc (NYSE: HIMS) saw its 5-day average volume 31.25 million, a positive change from its year-to-date volume of 9.32 million. As of the previous 9 days, the stock’s Stochastic %D was 9.94%. Additionally, its Average True Range was 2.55.
During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 44.31%, which indicates a significant increase from 22.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 175.71% in the past 14 days, which was higher than the 92.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.90, while its 200-day Moving Average is $17.13. Nevertheless, the first resistance level for the watch stands at $22.18 in the near term. At $23.36, the stock is likely to face the second major resistance level. The third major resistance level sits at $24.81. If the price goes on to break the first support level at $19.55, it is likely to go to the next support level at $18.10. The third support level lies at $16.92 if the price breaches the second support level.
Hims & Hers Health Inc (NYSE: HIMS) Key Stats
The company with the Market Capitalisation of 4.25 billion has total of 214,786K Shares Outstanding. Its annual sales at the moment are 872,000 K in contrast with the sum of -23,550 K annual income. Company’s last quarter sales were recorded 401,560 K and last quarter income was 75,590 K.
